Login / Signup

The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.

Julia LowinKavita SailRakhi BajYash J JalundhwalaThomas S MarshallHenrietta KonweaKallol Ray Chaudhuri
Published in: Journal of medical economics (2017)
LCIG is a cost-effective treatment option compared with SoC in patients with aPD.
Keyphrases
  • healthcare
  • palliative care
  • parkinson disease
  • quality improvement
  • combination therapy
  • chronic pain
  • health insurance